Document is current

Any future updates will be listed below

Erste orale Therapie spezifisch für aktive sekundär progrediente MS

Crossref DOI link: https://doi.org/10.1007/s15005-020-1425-z

Published Online: 2020-08-25

Published Print: 2020-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark